Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes

Topline data from the Phase II study for the treatment of diabetes are expected in the third quarter of 2026. -ASC30 ...
The Citizen

Ashton Ballito celebrates top results across IEB, Cambridge and IGCSE exams

Ashton International College Ballito has once again proven its academic excellence, celebrating outstanding results across the IEB, Cambridge AS & A-Levels and IGCSE examinations for the class of 2025 ...
FODMAP Everyday® on MSN

Why your shoes matter to flight attendants — plus 10 inside flying secrets

As soon as you board a plane, flight attendants notice details you might never consider, including your shoes. They aren’t ...